Trial intelligence / Profile preview

Lidocaine Infusion for Pain in Elderly Colorectal Cancer Surgery

NCT05920980Completed

Sponsor
West China Hospital of Sichuan University
Start
Jun 2023
Primary completion
Jan 2025
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in postoperative pain comparing Lidocaine Group with Placebo Group (2 arms). Primary endpoint: Pain scores of movement-evoked pain. Started Jun 2023; status: completed.

02

Drugs

Lidocaine Hydrochloride Injection, without epinephrine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT05920980.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05920980.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call